Treatment of red cell aplasia in CLL with fludarabine

The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function.

Annals of oncology : official journal of the European Society for Medical Oncology·2011

Proteolytic matrix metallopeptidases and inhibitors in BCR-ABL1-negative myeloproliferative neoplasms: correlation with JAK2 mutation status.

Acta haematologica·2011

Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS).

Leukemia·2008

Effect of HbS in the determination of HbA2 with the Menarini HA-8160 analyzer and comparison with other instruments.

International journal of laboratory hematology·2008

Long-term bone marrow cultures (LTBMC) from essential thrombocythemia (ET) patients with or without JAK2617V>F mutation.

Leukemia research·2008

Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG).

Annals of oncology : official journal of the European Society for Medical Oncology·2007

Selective dependency of CALR-mutant myeloproliferative neoplasms on TYK2 signaling.

Leukemia·2026

Aberrant expression of MERTK activates BCR via CD79a in CLL cells: alternative therapeutic strategy for relapsed/refractory CLL.

Leukemia·2026

C3- and C5-deficient murine cells exhibit severe mitochondrial defects, indicating a pivotal, novel role of innate immunity in regulating hematopoiesis at the electron transfer chain level.

Leukemia·2026

Clinical evaluation of AI-assisted quantitative marrow fibrosis assessment using Continuous Indexing of Fibrosis (CIF).

Leukemia·2026

Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia.

Leukemia·2026

Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.

Leukemia·2026

Myocarditis-Like Presentation Leads to DSP Arrhythmogenic Cardiomyopathy Diagnosis: From Variant of Uncertain Significance to Diagnosis.

JACC. Case reports·2026

Refining Allostatic Load Measurement: Mortality Associations of an Empirically Derived Three-Component Score in the Women's Health Initiative.

American journal of epidemiology·2026

Brensocatib in non-cystic fibrosis bronchiectasis: neutrophil serine protease modulation, clinical evidence, and therapeutic positioning.

Expert review of clinical pharmacology·2026

Persistent Right Ventricular Dysfunction and Hemodynamic Evolution Predict In-Hospital Deterioration in Intermediate-High- and High-Risk Pulmonary Embolism.

Arquivos brasileiros de cardiologia·2026

Effects of Pacemakers on Ventricular Functions and Early Variables Associated with Induced Cardiomyopathy.

Arquivos brasileiros de cardiologia·2026

[Influenza vaccination as an intervention for cardiovascular prevention and protection in high-risk patients. SIPREC/ANMCO/SIMI/FADOI/ARCA consensus document].

Giornale italiano di cardiologia (2006)·2026

Related Experiment Videos

Treatment of red cell aplasia in CLL with fludarabine

Related Concept Videos

The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function.

Proteolytic matrix metallopeptidases and inhibitors in BCR-ABL1-negative myeloproliferative neoplasms: correlation with JAK2 mutation status.

Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS).

Effect of HbS in the determination of HbA2 with the Menarini HA-8160 analyzer and comparison with other instruments.

Long-term bone marrow cultures (LTBMC) from essential thrombocythemia (ET) patients with or without JAK2617V>F mutation.

Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG).

Selective dependency of CALR-mutant myeloproliferative neoplasms on TYK2 signaling.

Aberrant expression of MERTK activates BCR via CD79a in CLL cells: alternative therapeutic strategy for relapsed/refractory CLL.

C3- and C5-deficient murine cells exhibit severe mitochondrial defects, indicating a pivotal, novel role of innate immunity in regulating hematopoiesis at the electron transfer chain level.

Clinical evaluation of AI-assisted quantitative marrow fibrosis assessment using Continuous Indexing of Fibrosis (CIF).

Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia.

Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.

Myocarditis-Like Presentation Leads to DSP Arrhythmogenic Cardiomyopathy Diagnosis: From Variant of Uncertain Significance to Diagnosis.

Refining Allostatic Load Measurement: Mortality Associations of an Empirically Derived Three-Component Score in the Women's Health Initiative.

Brensocatib in non-cystic fibrosis bronchiectasis: neutrophil serine protease modulation, clinical evidence, and therapeutic positioning.

Persistent Right Ventricular Dysfunction and Hemodynamic Evolution Predict In-Hospital Deterioration in Intermediate-High- and High-Risk Pulmonary Embolism.

Effects of Pacemakers on Ventricular Functions and Early Variables Associated with Induced Cardiomyopathy.

[Influenza vaccination as an intervention for cardiovascular prevention and protection in high-risk patients. SIPREC/ANMCO/SIMI/FADOI/ARCA consensus document].

Related Experiment Videos

Treatment of red cell aplasia in CLL with fludarabine

Related Concept Videos

Related Articles